Opium Tincture Deodorized

Manufacturer
Bryant Ranch Prepack
Effective date
2023-11-08
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
103
Source
full-release
Hydrated at
2026-05-31 21:07:29

Label at a glance#

ProductOpium Tincture Deodorized
Active ingredientMORPHINE
Label structure12 sections

Indications and uses

Opium tincture is useful for the treatment of diarrhea.

Dosage and administration

Usual Adult Dose – 0.6 mL orally 4 times a day.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Opium Tincture, USP (Deodorized), is for oral administration. It is freed from unpleasant odor or nauseating substances by “denarcotization” with a petroleum distillate. Opium tincture is a clear, reddish-brown hydroalcoholic solution.


Each 100 mL contains 1 g of anhydrous morphine (represents the equivalent of 10 g of Powdered Opium, USP), alcohol, 19%, and water.


Opium has a very characteristic odor and a very bitter taste. The opiates are the most effective and prompt-acting nonspecific antidiarrheal agents.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The opiates act by enhancing tone in the long segments of longitudinal muscle and by inhibiting propulsive contraction of both circular and longitudinal muscles.


Clinical evidence indicates that the analgesic activity of opium preparations is due to their morphine content. Relatively small doses that do not produce significant analgesia are effective in controlling diarrhea. The papaverine content of the mixed alkaloids is too small to have demonstrable spasmolytic activity.


Following oral administration, morphine is well absorbed from the gastrointestinal tract. It is rapidly metabolized following oral administration, however, and plasma levels of unconjugated morphine are lower than those achieved after parenteral administration. Like other narcotic analgesics, opium preparations are metabolized in the liver. Morphine undergoes conjugation with glucuronic acid at the 3-hydroxyl group. Secondary conjugation may also occur at the 6-hydroxyl group to form the 3,6-diglucuronide. Morphine is excreted in the urine mainly as morphine-3-glucuronide and smaller amounts of morphine-3,6-diglucuronide and unchanged drug. Approximately 75% of a dose of morphine is excreted in the urine within 48 hours.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Opium tincture is useful for the treatment of diarrhea.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This preparation is not recommended for use in children. It should not be used in diarrhea caused by poisoning until the toxic material is eliminated from the gastrointestinal tract.

WARNINGS

WARNINGS SECTION

Addiction can result from opium usage. Opium preparations should be given in the smallest effective dose and as infrequently as possible to minimize the development of tolerance and physical dependence.

PRECAUTIONS

PRECAUTIONS SECTION

General – Opium should be used with caution in the elderly, in debilitated individuals, and in patients with increased intracranial pressure, cerebral arteriosclerosis, hepatic cirrhosis or liver insufficiency, gastrointestinal hemorrhage, myxedema, emphysema, and bronchial asthma.


Drug Interactions – When preparations containing opium are administered in combination with other drugs, the cautions applicable to each ingredient should be borne in mind. Reduced dosage is indicated in poor-risk patients, in the very young or very old patient, and in those who are receiving other central-nervous system depressants.


Usage in Pregnancy - Pregnancy Category C – Animal reproduction studies have not been conducted with Opium Tincture, USP (Deodorized). It is also not known whether Opium Tincture, USP (Deodorized), can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Opium Tincture, USP (Deodorized), should be given to a pregnant woman only if clearly needed.


Nursing Mothers – Caution should be exercised when Opium Tincture, USP (Deodorized), is administered to a nursing woman.


Usage in Children – Safety and effectiveness in children have not been established.  See CONTRAINDICATIONS.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Constipation, nausea, and vomiting may occur in some patients. Pruritus and urticaria have been observed.

DRUG ABUSE AND DEPENDENCE

DRUG ABUSE AND DEPENDENCE SECTION

Controlled Substance – Opium Tincture, USP (Deodorized), is a Schedule II drug. See WARNINGS.

OVERDOSAGE

OVERDOSAGE SECTION

Signs and Symptoms – Symptoms of toxicity are those of morphine and alcohol, such as nausea, vomiting, miosis, cool and clammy skin, respiratory and CNS depression, bradycardia, hypotension, and skeletal muscle flaccidity. Noncardiogenic pulmonary edema may develop after opioid overdose and monitoring of heart filling pressure may be helpful. Ethanol has been demonstrated to cause hypoglycemia in children or adults with limited glycogen stores. In severe overdosage, apnea, circulatory collapse, cardiac arrest, and death may occur.


Treatment – To obtain up-to-date information about the treatment of overdose, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the Physicians’ Desk Reference (PDR). In managing overdosage, consider the possibility of multiple drug overdoses, interaction among drugs, and unusual drug kinetics in your patient.


Initial management of opioid overdose should emphasize establishment of a secure airway and support of ventilation and perfusion. Meticulously monitor and maintain, within acceptable limits, the patient’s vital signs, blood gases, serum electrolytes, blood glucose, etc. Naloxone antagonizes most effects of opioids. Protect the airway as naloxone may induce vomiting. Since naloxone has a shorter duration of action than opioids, repeated doses may be needed. In patients who abuse opioids chronically, a withdrawal syndrome may be manifest on administration of naloxone. This may include yawning, tearing, restlessness, sweating, dilated pupils, piloerection, vomiting, diarrhea, and abdominal cramps. This syndrome usually abates quickly as the effect of naloxone dissipates.


Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than emesis or lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Since opium tincture can delay gastric emptying, evacuation of the stomach may be beneficial. Safeguard the patient’s airway when employing gastric emptying or charcoal.

Monitor for and treat hypoglycemia.

The use of forced diuresis, peritoneal dialysis, hemodialysis or charcoal hemoperfusion has not been established to be beneficial.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Usual Adult Dose – 0.6 mL orally 4 times a day.

HOW SUPPLIED

HOW SUPPLIED SECTION

Opium Tincture, USP (Deodorized), is supplied as:
NDC 63629-1965-1

Bottles of 4 fl oz

Dispense in tightly closed containers.
Store at controlled room temperature, 68° to 77°F (20° to 25°C) (see USP).

Repackaged/Relabeled by:
Bryant Ranch Prepack, Inc.
Burbank, CA 91504

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Opium Tincture USP (Deodorized), 10 mg/mL of anhydrous morphine (CII)

LabelLabel

Extended Label

Extended LabelExtended Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
830196opium tincture 10 MG (as morphine equivalent) in 1 mL Oral SolutionPSN103
830196opium tincture 100 MG/ML Oral SolutionSCD103
830196anhydrous morphine 1 % Oral SolutionSY103
830196anhydrous morphine 10 MG/ML Oral SolutionSY103
830196opium tincture 10 % Oral SolutionSY103
830196opium tincture 10 MG (as morphine equivalent) per 1 ML Oral SolutionSY103

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MORPHINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
89941d4c-522d-cee0-b273-43cfa7ef6d35Product name420250516
f15f9e76-db42-8a50-218a-5ef5affa58daProduct name420240216
944b0689-73f4-6a2f-c654-1180896353c0Product name420220210
67e166c6-23d4-4709-b77d-5ca6182dcae0Product name120180830
c573a64c-fe17-2eac-fbcb-788868b4ff6bProduct name920180619
7c1819cf-69a0-41dc-aeaa-a820729bc959Product name120170406
7a68fc31-10e5-df04-67e0-3a613a2d4d2eProduct name520161114
175682a8-c657-45a2-9dfb-c565306b03c8Product name120160112
b73dadd0-1b4a-4f88-956f-a2be216c8fadProduct name120151123
4c272b1c-87fc-ebc0-994d-ac28b1e0416eProduct name120140508
7a537f54-d322-5e54-a3a2-035d3e21c3c6Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-1965-1Opium Tincture Deodorized118 mL in 1 BOTTLESOLUTION118103

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-1965OPIUM TINCTURE DEODORIZED (MORPHINE TINCTURE) SOLUTION [BRYANT RANCH PREPACK]103Current NDC, Legacy NDC, 1 package rows20240711_5c1ddfd9-b0be-4e7f-a48c-68f8dc96e672.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63629-1965-1ML - Milliliter63629-19652ec8eabb-1887-44ab-ba90-ec932932f47012021-03-02
62559-153-04ML - Milliliter62559-153a47b13b5-78ef-4db8-93a4-5f89b76ca4d812012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63629-196563629-1965-1
62559-153

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
MORPHINE76I7G6D29CACTIB
ALCOHOL3K9958V90MIACT
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Opium Tincture DeodorizedMORPHINE TINCTUREANI Pharmaceuticals, Inc.674a969a-707d-41a9-b7c3-b90cbf2909e32025-09-08Warnings, Adverse reactionsExact identifier
ndc (product): 62559-153
Opium Tincture DeodorizedMORPHINE TINCTUREBryant Ranch Prepack5c1ddfd9-b0be-4e7f-a48c-68f8dc96e6722023-11-08Warnings, Adverse reactionsExact identifier
ndc (package): 63629-1965-1
ndc (product): 63629-1965
ndc11 (package): 63629196501
spl id: d3644205-5115-46c7-97f9-e6d2f54baa56
spl set id: 5c1ddfd9-b0be-4e7f-a48c-68f8dc96e672

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.